Search
Acitretin
go.drugbank.com/drugs/DB00459ApprovedInvestigationalAn oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate.
Products: NOVATRETIN CAPSULE 10MG, Novatretin 10mg CapsulesAripiprazole
go.drugbank.com/drugs/DB01238ApprovedInvestigational[L45859,A4393] Aripiprazole was given FDA approval on November 15, 2002.[L6136] … [L45859] It is also indicated as an injection for agitation associated with schizophrenia or bipolar mania.
Products: ARIAN 10MG TABLETS (Aripiprazole USP 10mg Tablets), ARIGEN 10MGAvobenzone
go.drugbank.com/drugs/DB09495ApprovedInvestigationalAvobenzone has the ability to absorb ultraviolet light over wider range of wavelengths. It is included in many commercially available sunscreens which are used as wide spectrum sunscreens. … Avobenzone has an absorption maximum of 357 nm. Sunscreens containing avobenzone is indicated for providing protection from the sun.
Mixtures: Naked Sundays Golden Glow Body Sunscreen SPF50 100ml, Olay Professional ProX Age Repair SPF 30Products: Naked Sundays Golden Glow Body Sunscreen SPF50 100mlCorifollitropin alfa
go.drugbank.com/drugs/DB09066ApprovedInvestigationalMultiple studies and a meta-analysis suggest that corifollitropin alfa is as efficacious as recombinant FSH in terms of live birth rate, ongoing pregnancy rate, as well as clinical pregnancy rate. … Corifollitropin alfa is marketed as Elonva in more than 75 countries [L2272]. Corifollitropin alfa is produced by a method known as ‘recombinant DNA technology’.
Products: Elonva Solution for Injection 100mcg/0.5ml, Elonva (solution for injection 100mcg/0.5ml)Idarubicin
go.drugbank.com/drugs/DB01177ApprovedInvestigationalThe compound has shown activity against breast cancer, lymphomas and leukemias, together with the potential for reduced cardiac toxicity.
Products: Idamycin - Cap 10mg, Idamycin Pws 10mg/vialIoxitalamic acid
go.drugbank.com/drugs/DB13444ApprovedWithdrawn[A33006] Ioxitalamic acid in the salt forms of sodium and meglumine was developed by Liebel-Flarshem Canada Inc and approved by Health Canada in 1995.
Products: TELEBRIX 30 MEGLUMINE,100MLOlmesartan
go.drugbank.com/drugs/DB00275ApprovedInvestigational[A175330] It was developed by Daiichi Sankyo Pharmaceuticals and approved in 2002.[A175345, L12882] … The angiotensin II receptor blocker (ARB) family of drugs unique in that it blocks all angiotensin II activity, regardless of where or how it was synthesized.
Mixtures: VOCADO 40MG/10MG, VOCADO 40MG/10MGProducts: VOTUM 10MG, OLMETEC 10MGZoledronic acid
go.drugbank.com/drugs/DB00399ApprovedInvestigational[L13712,L13715,L13721] Zoledronic acid was first described in the literature in 1994.[A203120] Zoledronic acid was granted FDA approval on 20 August 2001.[L13712]
Products: ASZORA 4MG/100ML, ZOMETA 4MG/100MLLemborexant
go.drugbank.com/drugs/DB11951ApprovedInvestigational[L10863] Recent research in the field of sleep disorders has revealed that insomnia is likely driven not by the inability of the brain to "switch on" sleep-related circuits, but rather an inability to
Products: DAYVIGO FILM-COATED TABLET 10MG, Dayvigo 10mg Film coated tabletBrigatinib
go.drugbank.com/drugs/DB12267ApprovedInvestigational[A31313] Brigatinib was developed by Ariad Pharmaceuticals, a subsidiary of Takeda Pharmaceutical Company Limited, and FDA-approved on April 28, 2017.[L1026]
Products: ALUNBRIG FILM-COATED TABLET 180mg, Alunbrig (Brigatinib) 180mg Film-Coated Tablet